Searchable abstracts of presentations at key conferences in endocrinology

ea0056p137 | Endocrine tumours and neoplasia | ECE2018

Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.

Papalou Olga , Kandaraki Eleni , Papadakis Georgios , Nikou Georgios , Diamanti-Kandarakis Evanthia

Introduction: Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors arising from neuroendocrine cells in the endocrine and central nervous system, the natural history of which remains inadequately understood. Large epidemiological studies are gradually emerging from different countries worldwide, which contribute to the establishment of a spherical view about these tumors. The purpose of this study is to evaluate the epidemiological, clinical and pathological cha...

ea0056p556 | Obesity | ECE2018

Menopausal hormone therapy is associated with reduced fat mass and in particular a significant decrease of the intravisceral abdominal fat, the OsteoLaus cohort

Papadakis Georgios , Hans Didier , Vollenweider Peter , Gonzalez Rodriguez Elena , Waeber Gerard , Marques-Vidal Pedro , Lamy Olivier

Background: We previously showed that menopausal hormone therapy (MHT) favorably affects both bone density and microarchitecture with persistent benefit after its withdrawal (1). Looking for indirect factors contributing to bone effects, we investigated the relation between MHT and changes on fat and lean (muscular) tissue. Existing results on MHT and body composition are conflicting and large cohort studies are lacking.Material and methods: The OsteoLau...

ea0056ep145 | Reproductive Endocrinology | ECE2018

The combination of cardiovascular risk factors in PCOS and the risk for cardiovascular disease events

Papadakis Georgios , Kandaraki Eleni , Papalou Olga , Vryonidou Andromachi , Diamanti-Kandarakis Evanthia

Objectives: • PCOS is defined by the presence of hyperandrogenism (clinical and/or biochemical), ovarian dysfunction (oligo-anovulation and/or polycystic ovaries), and the exclusion of related disorders.• Women are exposed to increased risk for cardiovascular disease, hypertension, type 2 diabetes mellitus and other metabolic complications• Cardiovascular disease (CVD) is one of the most common cause of mortality wor...

ea0099p555 | Reproductive and Developmental Endocrinology | ECE2024

Klinefelter syndrome is associated with early-onset metabolic defects that are not reversed by testosterone therapy

Chouchane Karim , Hofbauer Susanna , Giordani Ilaria , nathalie vionnet , Barigou Mohammed , Pitteloud Nelly , Hauschild Michael , Papadakis Georgios

Background: Klinefelter syndrome (KFS) is the most common chromosomal aberration in men, characterized by an extra-X chromosome (47, XXY). Besides the well-known reproductive defects, KFS is characterized by a 4-fold increase in metabolic syndrome, cardiovascular morbidity and mortality. The exact cause of this constellation remains unclear.Methods: Data from non-mosaic KFS adults and adolescents, evaluated in the endocrine unit of Lausanne University Ho...

ea0049ep1098 | Female Reproduction | ECE2017

Association of basal and post-synacthen stimulated 17-hydroxyprogesterone levels with insulin resistance in polycystic ovary syndrome

Kandaraki Eleni , Papadakis Georgios , Tsirona Sofia , Asimakopoulou Athina , Chiotinis Nikolaos , Chronopoulou Genovefa , Kassi Georgia , Diamanti-Kandarakis Evanthia

Objective: 17-alpha-hydroxyprogesterone caproate therapy during pregnancy has been associated with insulin resistance. The aim of this study was to highlight any possible association of 17OHP with insulin resistance in women with PCOS.Design: Forty-five women with PCOS underwent 75 g OGTT test and short Synachten test with sampling of stimulated 17OHP. Women were divided into two subgroups according to basal 17OHP cut-off level of 0.8 ng/ml.<p class=...

ea0049ep1373 | Thyroid (non-cancer) | ECE2017

Unilateral Graves’ disease with papillary carcinoma of the hyperfunctioning lobe

Papadakis Georgios , Rodriguez Elena Gonzalez , Allenbach Gilles , Lalonde Marie Nicod , Gorostidi Francois , Sandu Kishore , Bongiovanni Massimo , Sykiotis Gerasimos P.

Background: Graves’ disease (GD) typically manifests as an autoimmune hyperfunction of both thyroid lobes. Less than 10 cases of unilateral GD have been described, and the pathophysiology of unilateral GD remains unknown. Co-existence of malignancy has never been reported. We report a case of GD of the left lobe with simultaneous discovery of a papillary carcinoma within the hyperfunctioning lobe.Case description: A 49-year-old patient of Middle-Eas...

ea0041ep251 | Clinical case reports - Pituitary/Adrenal | ECE2016

21-hydroxylase deficiency presenting as bilateral adrenal masses in the sixth decade of life in a phenotypically male but genetically female patient

Panagiotidi Evgenia , Papadakis Georgios , Manitarou Paraskevi , Tzaves Ioannis , Triantafillou Eleni , Kalaitzidou Styliani , Sapera Aggeliki , Katsoulis Konstantinos , Kaltzidou Victoria , Tertipi Athanasia

Introduction: 21-hydroxylase deficiency (21-OHD) is a common inherited disorder accounting for 90–95% of congenital adrenal hyperplasia (CAH) cases. Some cases may be diagnosed in adulthood after the incidental discovery of adrenal masses on computerized tomography (CT).Case report: A 59-year-old male was investigated for incidentally discovered bilateral adrenal masses in an abdomen CT scan, measuring 5 cm on the right and 8 cm on the left adrenal....

ea0041ep906 | Pituitary - Clinical | ECE2016

Quality of life in patients with acromegaly and the effect of somatostatin analogues

Kaldrymidis Dimitrios , Papadakis Georgios , Tsakonas Georgios , Kostoglou-Athanassiou Ifigenia , Kaldrymidis Philippos , Peppa Melpomeni , Roussou Paraskevi , Diamanti-Kandarakis Evanthia

Objective: Quality of life is currently considered a major factor in the assessment of disease outcome. The aim was to assess quality of life in acromegaly and the effect of somatostatin analogues on it.Design: This study included 101 patients with acromegaly, mean age 59.51±1.35 years (mean ± S.E.M.), with a disease duration of 12.88±0.96 years. All subjects completed the Acromegaly Quality of Life Questionnaire (AcroQoL) w...

ea0037ep235 | Calcium and Vitamin D metabolism | ECE2015

Vitamin D and seasonal variation among Greek female patients with osteoporosis

Papadakis Georgios , Keramidas Ioannis , Kakava Kassiani , Pappa Theodora , Villiotou Vassiliki , Manitarou Paraskevi , Kalaitzidou Styliani , Triantafillou Eleni , Kaltzidou Victoria , Pappas Anastasios

Background: 25 hydroxy vitamin D (25(OH)D) vitamin levels are positively associated with bone mineral density and season, time of day and sun exposure duration influence its synthesis. Variations in daylight throughout the year and zenith angle, depending on the latitude of residence, influence u.v. solar radiation which is closely related to serum 25(OH)D levels. The aim of this study was to investigate the degree of seasonal variation of 25(OH)D serum levels in a population-...

ea0037ep846 | Thyroid cancer | ECE2015

Association of calcium-stimulated calcitonin values with pathological findings following total thyroidectomy

Papadakis Georgios , Keramidas Ioannis , Triantafillou Eleni , Kanouta Foteini , Pappa Theodora , Kaltzidou Victoria , Tertipi Athanasia , Vecchini Gino , Papadouli Despoina , Pappas Anastasios

Background and objectives: Medullary thyroid carcinoma (MTC) originates from thyroid C-cells and is a calcitonin (CT) secreting tumour with aggressive behaviour. Surgery is recommended in all patients with basal or calcium-stimulated CT values of 100 pg/ml or higher due to the high probability of MTC. The objective of this study was to investigate the utility of calcium stimulation test for CT in order to distinguish MTC from C-cell Hyperplasia (CCH) preoperatively and to exam...